I now have excellent source material to give a thorough answer. Here is the full response:
Diagnosis: Acute Leukemia (most likely Acute Myeloid Leukemia, AML)
This patient's presentation is a textbook case of acute leukemia. Let's break down how each finding points to the diagnosis:
Connecting the Dots
| Clinical Finding | Pathophysiologic Explanation |
|---|
| Fatigue, pallor | Anemia from bone marrow infiltration by blasts (cytopenias) |
| Gum bleeding, heavy menstrual bleeding, petechiae | Thrombocytopenia - blasts crowd out normal platelet-producing megakaryocytes |
| Splenomegaly | Extramedullary infiltration of the reticuloendothelial system by leukemic cells |
| Markedly elevated WBC | Massive proliferation of malignant blast cells (leukocytosis/hyperleukocytosis) |
| Age 22, female | Both AML and ALL affect young adults; ALL peaks 3-5 years in children, AML becomes more common with age |
As stated in Tintinalli's Emergency Medicine: "Cytopenias from marrow infiltration can present as pallor, easy bleeding/bruising with petechiae and ecchymoses, infections, or bone pain. The reticuloendothelial system is the most common site of extramedullary infiltration, manifesting as hepatomegaly, splenomegaly, and/or lymphadenopathy."
Why AML vs. ALL?
While both are possible, AML is more likely here given:
- Hyperleukocytosis (markedly elevated WBC) is more commonly associated with AML
- Gingival/mucosal bleeding is characteristic of AML - gum infiltration (leukemia cutis/gingiva) is a hallmark of AML, especially the monocytic subtypes (M4/M5)
- Heavy menstrual bleeding strongly suggests significant thrombocytopenia and possibly DIC (disseminated intravascular coagulation), which is classically associated with AML-M3 (Acute Promyelocytic Leukemia, APL) - a critical subtype to consider
AML-M3 (APL) deserves special mention: It is particularly associated with life-threatening bleeding due to DIC and should be considered an emergency. It is treated with all-trans retinoic acid (ATRA) + arsenic trioxide.
Diagnostic Criteria
The diagnosis of AML requires ≥20% blasts in the bone marrow or peripheral blood (WHO classification). Workup should include:
- CBC with differential and peripheral blood smear - look for blast cells, often showing Auer rods (pathognomonic for AML)
- Bone marrow aspirate and biopsy - definitive diagnosis; blast percentage, morphology
- Immunophenotyping (flow cytometry) - myeloid markers: MPO, CD13, CD33, CD117
- Cytogenetics and molecular studies - e.g., t(15;17) in APL, FLT3 and NPM1 mutations in AML
- Coagulation profile (PT, aPTT, fibrinogen, D-dimer) - screen for DIC
- Serum chemistries - LDH, uric acid, electrolytes (tumor lysis risk)
Summary
The diagnosis is Acute Leukemia, and with this specific constellation (young woman, mucosal/uterine bleeding, splenomegaly, markedly elevated WBC), Acute Myeloid Leukemia (AML) is the leading diagnosis - with Acute Promyelocytic Leukemia (APL/AML-M3) being the most urgent subtype to rule out due to its associated life-threatening coagulopathy.
- Tintinalli's Emergency Medicine: A Comprehensive Study, Clinical Features of Acute Leukemia
- Henry's Clinical Diagnosis and Management by Laboratory Methods, Acute Myeloid Leukemia